passages.id: split_1_test_2279_passage
passages.type: progene_text
passages.text: Oprelvekin is also undergoing phase I clinical trials for colitis [ 396157 ] , phase II clinical trials for rheumatoid arthritis [ 413835 ] and clinical trials for psoriasis [ 299644 ] .